Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

1(50.0%)

Phase 4

1(50.0%)

2Total

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02295306Active Not Recruiting

Overnight Polysomnography and Respiratory Volume Monitor

Role: collaborator

NCT02310230Not ApplicableCompleted

An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy

Role: collaborator

NCT02728726Phase 4Completed

Sugammadex vs Placebo to Prevent Residual Neuromuscular Block

Role: collaborator

NCT02903173Completed

An Observational Study of Post-cesarean Delivery Respiratory Patterns Using a Non-invasive Minute Ventilation Monitor (Exspiron ™ System)

Role: collaborator

NCT03039881Completed

Evaluation of Non-Invasive Respiratory Volume Monitor

Role: collaborator

NCT02690298Completed

Evaluation of ExSpiron™ Measurements Derived Without Patient Specific Calibration

Role: lead

All 6 trials loaded